Clinical Trials Directory

Trials / Completed

CompletedNCT04236830

Silver Diamine Fluoride/ Potassium Iodide in Indirect Pulp Capping of Young Permanent Molars

Effectiveness of Silver Diamine Fluoride/ Potassium Iodide in Indirect Pulp Capping of Young Permanent Molars (a Randomized Controlled Clinical Trial)

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
108 (actual)
Sponsor
Nourhan M.Aly · Academic / Other
Sex
All
Age
6 Years – 9 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate and compare the clinical effectiveness of 38% silver diamine fluoride with and without potassium iodide with that of resin modified glass ionomer cement in indirect pulp capping of young permanent molars.

Detailed description

A sample of children with an age range of 6-9 years, having a first permanent molar erupted with deep occlusal carious lesion, will be selected from the outpatient clinic of Pediatric Dentistry and Public Health Department, Faculty of Dentistry, Alexandria University after securing necessary consents. All selected 108 first permanent molars will be randomly equally allocated into three groups according to capping material used. Group I (n=36) SDF/ KI and Group II (n=36) SDF and Group III (n=36) Glass ionomer cement. Indirect pulp capping treatment procedure will be performed with identical protocols except for the capping material to be used and its application will be according to manufacturer's instructions. Glass ionomer cement will be used as a base and resin-based composite restoration will be used in the three groups.

Conditions

Interventions

TypeNameDescription
DRUGSilver diamine fluoride/ potassium iodideThirty six first permanent molars will receive 38% SDF/KI as an indirect pulp capping material.
DRUGSilver diamine fluorideThirty six first permanent molars will receive 38% SDF as an indirect pulp capping material.
DRUGResin modified glass ionomer cementThirty six first permanent molars will receive RMGIC as an indirect pulp capping material.

Timeline

Start date
2019-11-01
Primary completion
2021-03-01
Completion
2021-03-25
First posted
2020-01-22
Last updated
2022-05-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04236830. Inclusion in this directory is not an endorsement.